Jeffrey I Zwicker

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Tissue factor-bearing microparticles and cancer
    Jeffrey I Zwicker
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Semin Thromb Hemost 34:195-8. 2008
  2. ncbi Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
    Jeffrey I Zwicker
    Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Clin Cancer Res 15:6830-40. 2009
  3. ncbi Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia
    J I Zwicker
    Hematology Oncology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Thromb Haemost 2:2133-7. 2004
  4. ncbi Measurement of platelet microparticles
    Jeffrey I Zwicker
    Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Methods Mol Biol 788:127-39. 2012
  5. ncbi Impedance-based flow cytometry for the measurement of microparticles
    Jeffrey I Zwicker
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Semin Thromb Hemost 36:819-23. 2010
  6. ncbi Predictive value of tissue factor bearing microparticles in cancer associated thrombosis
    Jeffrey I Zwicker
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
    Thromb Res 125:S89-91. 2010
  7. ncbi Cancer-associated thrombosis
    Jeffrey I Zwicker
    Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center and the Department of Medicine, Harvard Medical School, Boston, MA 02115, United States
    Crit Rev Oncol Hematol 62:126-36. 2007
  8. ncbi The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size
    Jeffrey I Zwicker
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Blood 108:1280-3. 2006
  9. ncbi Tissue factor-bearing microparticles and thrombus formation
    Jeffrey I Zwicker
    Division of Hemostasis, Harvard Medical School, Thrombosis Beth Israel Deaconess Medical Center, 330 Brookline Ave E CLS 903, Boston, MA 02215, USA
    Arterioscler Thromb Vasc Biol 31:728-33. 2011
  10. ncbi Accounting for death as a competing risk in cancer-associated thrombosis studies
    Federico Campigotto
    Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Thromb Res 129:S85-7. 2012

Research Grants

  1. Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
    Jeffrey Zwicker; Fiscal Year: 2007

Detail Information

Publications11

  1. ncbi Tissue factor-bearing microparticles and cancer
    Jeffrey I Zwicker
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Semin Thromb Hemost 34:195-8. 2008
    ..We are currently using an impedance-based flow cytometer to accurately size and enumerate TF-bearing microparticles to explore the association between cancer thrombosis and elevations in circulating TF-bearing microparticles...
  2. ncbi Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
    Jeffrey I Zwicker
    Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Clin Cancer Res 15:6830-40. 2009
    ..We evaluated the hypothesis that tumor-derived tissue factor-bearing microparticles in plasma contribute to cancer-associated thrombosis...
  3. ncbi Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia
    J I Zwicker
    Hematology Oncology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Thromb Haemost 2:2133-7. 2004
    ....
  4. ncbi Measurement of platelet microparticles
    Jeffrey I Zwicker
    Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Methods Mol Biol 788:127-39. 2012
    ..We describe methodology for light scatter-based flow cytometry as well as impedance-based flow cytometry for the enumeration and characterization of platelet microparticles...
  5. ncbi Impedance-based flow cytometry for the measurement of microparticles
    Jeffrey I Zwicker
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Semin Thromb Hemost 36:819-23. 2010
    ..This review details the rationale for employing impedance-based flow cytometry in the measurement of blood-borne microparticles...
  6. ncbi Predictive value of tissue factor bearing microparticles in cancer associated thrombosis
    Jeffrey I Zwicker
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
    Thromb Res 125:S89-91. 2010
    ..This review details the evidence for tissue factor bearing microparticles in the malignant state and its association with thromboembolic phenomena...
  7. ncbi Cancer-associated thrombosis
    Jeffrey I Zwicker
    Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center and the Department of Medicine, Harvard Medical School, Boston, MA 02115, United States
    Crit Rev Oncol Hematol 62:126-36. 2007
    ....
  8. ncbi The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size
    Jeffrey I Zwicker
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Blood 108:1280-3. 2006
    ....
  9. ncbi Tissue factor-bearing microparticles and thrombus formation
    Jeffrey I Zwicker
    Division of Hemostasis, Harvard Medical School, Thrombosis Beth Israel Deaconess Medical Center, 330 Brookline Ave E CLS 903, Boston, MA 02215, USA
    Arterioscler Thromb Vasc Biol 31:728-33. 2011
    ..Only a subpopulation of these microparticles expresses tissue factor...
  10. ncbi Accounting for death as a competing risk in cancer-associated thrombosis studies
    Federico Campigotto
    Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Thromb Res 129:S85-7. 2012
    ..This review describes the theoretical and mathematical basis for estimating the cumulative incidence function by the competing risk model for the analysis of VTE outcomes in cancer-associated thrombosis...
  11. ncbi Timing of postpartum enoxaparin administration and severe postpartum hemorrhage
    Rachel A Freedman
    Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
    Blood Coagul Fibrinolysis 19:55-9. 2008
    ..Severe postpartum hemorrhage is an infrequent complication when enoxaparin is administered to hemostatically intact women between 5 and 24 h following a vaginal delivery or 12-36 h following cesarean section...

Research Grants2

  1. Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome
    Jeffrey Zwicker; Fiscal Year: 2007
    ....